KROS
Keros Therapeutics Inc
NASDAQ: KROS · HEALTHCARE · BIOTECHNOLOGY
$10.99
-0.47% today
Updated 2026-06-03
Market cap
$203.86M
P/E ratio
—
P/S ratio
6.14x
EPS (TTM)
$-2.53
Dividend yield
—
52W range
$10 – $23
Volume
0.3M
Keros Therapeutics Inc (KROS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
—
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|